With a focus on research and development, we strive to create high-quality, effective medicines that meet international standards
References Physicochemical characteristics of LR3-IGF1 protein inclusion bodies: electrophoretic mobility studies Optimizing IGF-I for skeletal muscle therapeutics Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats Effects of insulin-like growth factor-1/binding protein-3 complex on muscle atrophy in rats Use of Growth Hormone, IGF-I, and Insulin for Anabolic Purpose: Pharmacological Basis, Methods of Detection, and Adverse Effects
BPC157 appears to support the gut lining and reduce inflammation in animal models
Uterine Smooth Muscle Tumours with Hyperintense Area on T1 Weighted Images: Differentiation between Leiomyosarcomas and Leiomyomas
Despite the short plasma half-life, downstream biological effects in tissue persist substantially longer, consistent with a signaling cascade rather than direct dose-response activity
Effective doses typically range from 250-500mg daily